SEC Form 4 · accession 0001144204-18-001799
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen P. Bloch
Officer — Chief Financial Officer
Period of report
Jan 8, 2018
Accepted (ET)
Jan 10, 2018 · 9:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 8, 2018 | M | 20,000 | $2.90 | A | 248,638 | D | |
| Common Stock | Jan 8, 2018 | M | 12,400 | $4.69 | A | 261,038 | D | |
| Common Stock | Jan 8, 2018 | S | 10,000 | $7.15 | D | 251,038 | D | |
| Common Stock | Jan 8, 2018 | S | 12,400 | $7.25 | D | 238,638 | D | |
| Common StockF2 | Jan 8, 2018 | S | 10,000 | $7.50 | D | 228,638 | D | |
| Common StockF3 | holding | — | — | — | 9,000 | I | See Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.90 | Jan 8, 2018 | M | 20,000 | D | May 29, 2015 | May 29, 2023 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (Right to Buy) | $4.69 | Jan 8, 2018 | M | 12,400 | D | Jan 30, 2017 | Jun 7, 2026 | Common Stock | 12,400 | 49,600 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2017.
- F2Includes (i) the following restricted stock units that will be settled into common stock upon vesting upon a "Change In Control" of CytoSorbents Corporation, as defined in the CytoSorbents Corporation 2014 Long-Term Incentive Plan: (a) 15,700 restricted stock units granted on February 24, 2017, (b) 47,000 restricted stock units granted on June 7, 2016 and (c) 110,000 restricted stock units granted on April 8, 2015, (ii) the following restricted stock units subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting: (a) 32,813 restricted stock units granted on February 24, 2017 and (b) 21,000 restricted stock units granted on June 7, 2016 and (iii) 2,125 shares of common stock owned by the reporting person.
- F3These shares are held by the reporting person's husband in a 401(k) account and, as such, the reporting person may be deemed the beneficial owner of such shares.